Long-term treatment of chronic hepatitis B / 中华肝脏病杂志
Chinese Journal of Hepatology
; (12): 884-890, 2014.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-337044
Responsible library:
WPRO
ABSTRACT
Nucleoside and nucleotide analogs (NAs) have been successfully used for treatment of chronic hepatitis B. Hepatitis B virus (HBV) replication is now recognized as the key driver of liver injury and disease progression, so the primary aim of treatment for chronic HBV infection is to maximize sustained suppression of HBV replication to undetectable levels. The long-term treatment has also been shown to achieve substantial histological improvement and regression of liver fibrosis or cirrhosis, and reduction of hepatocellular carcinoma. This paper has reviewed the necessity, clinical benefits, and the management of long-term treatment for chronic hepatitis B.
Full text:
Available
Health context:
SDG3 - Health and Well-Being
Health problem:
Target 3.3: End transmission of communicable diseases
Database:
WPRIM (Western Pacific)
Main subject:
Antiviral Agents
/
Virus Replication
/
Hepatitis B virus
/
Carcinoma, Hepatocellular
/
Hepatitis B, Chronic
/
Liver Cirrhosis
/
Nucleosides
Limits:
Humans
Language:
Chinese
Journal:
Chinese Journal of Hepatology
Year:
2014
Document type:
Article